Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Natera Inc (NTRA) USD0.0001

Sell:$37.15 Buy:$37.19 Change: $0.28 (0.75%)
NASDAQ:0.44%
Market closed |  Prices as at close on 11 December 2019 | Switch to live prices |
Sell:$37.15
Buy:$37.19
Change: $0.28 (0.75%)
Market closed |  Prices as at close on 11 December 2019 | Switch to live prices |
Sell:$37.15
Buy:$37.19
Change: $0.28 (0.75%)
Market closed |  Prices as at close on 11 December 2019 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Natera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).

Contact details

Address:
201 Industrial Rd Ste 410
SAN CARLOS
94070-2396
United States
Telephone:
+1 (650) 2499090
Website:
www.natera.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
NTRA
ISIN:
US6323071042
Market cap:
$2.82 billion
Shares in issue:
77.53 million
Sector:
Biotechnology
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Matthew Rabinowitz
    Executive Chairman of the Board, Co-Founder
  • Steven Chapman
    President, Chief Executive Officer, Director
  • Jonathan Sheena
    Co-Founder, Chief Technology Officer, Director
  • Michael Brophy
    Chief Financial Officer
  • Robert Schueren
    Chief Operating Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.